RegenHU
RegenHU is a Swiss Med Tech company that designs and manufactures 3D bioprinting instruments (R-GEN 100 and R-GEN 200) and SHAPER software for academic researchers, pharmaceutical companies, and cosmetics firms developing tissue models, drug discovery assays, and personalized therapeutics.
- Company typePrivate
- Founded2007
- HeadquartersVillaz-saint-pierre, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What RegenHU does
RegenHU is a privately held Swiss Med Tech company founded in 2007 and headquartered in Villaz-St-Pierre, Switzerland. The company designs and manufactures 3D bioprinting instruments — primarily the R-GEN 100 and R-GEN 200 systems — paired with its proprietary SHAPER software for designing 2D and 3D constructs and managing biofabrication workflows. Its core technology integrates multiple printing modalities (cell suspensions, thermoplastics, and biomaterials) within a single robotic platform, enabling applications in human skin printing, cellular drug discovery models, and personalized tablet formulation.
The company serves a diversified customer base spanning academic research institutions (ETH Zurich, TU Berlin, University of Minnesota, Trinity College, University of Michigan, UMC Utrecht), pharmaceutical R&D (Novartis), and cosmetics (L'Oreal). A database of 732 scientific publications referencing RegenHU technology demonstrates established adoption across the global research community. Customer support is delivered through a scientific advisory team, technical engineering hotline, and the RegenHU Bioprinting Academy for training.
RegenHU generates revenue primarily through capital equipment sales (R-GEN bioprinters), supplemented by software licenses (SHAPER) and professional services (training and support). The company operates a consultative, sales-led GTM motion with quote-based pricing and direct engagement. Cumulative disclosed funding since inception totals approximately $700K across multiple small rounds led by NIVALIS Group and Venture Kick, with no rounds reported after 2015, indicating a bootstrapped or organically financed operating model.
RegenHU firmographics
Firmographics- Name
- RegenHU
- Legal name
- regenHU
- Website
- https://regenhu.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- RegenHU is a Swiss Med Tech company that designs and manufactures 3D bioprinting instruments (R-GEN 100 and R-GEN 200) and SHAPER software for academic researchers, pharmaceutical companies, and cosmetics firms developing tissue models, drug discovery assays, and personalized therapeutics.
- Ownership category
- akta.pro rank
RegenHU industry classification
Industry- Product category
- 3D Bioprinting Instruments and Biofabrication Equipment
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware) (IMAAAAAG)
- akta.pro secondary industry
- 3D Bioprinting & Biofabrication (HLAAAGAC)
Keywords
Where RegenHU is headquartered
LocationHeadquarters
- HQ city
- Villaz-saint-pierre
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
RegenHU business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Revenue model
- 3D Bioprinting Instruments: Sale of bioprinting hardware including R-GEN 100 and R-GEN 200 systems for tissue models, drug development, and tablet formulation
- Software Licenses: SHAPER software for bioprinting design and process management
- Support and Training Services: RegenHU Bioprinting Academy training, technical engineering support via hotline, and scientific advisory services for instrument selection and protocol development
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
RegenHU product offering
Product offeringCore offering
RegenHU develops, manufactures, and sells 3D bioprinting instruments and software used by research and pharmaceutical organizations to fabricate tissue models, drug discovery cellular models, and personalized pharmaceutical tablets. Its product platform comprises the R-GEN 100 and R-GEN 200 bioprinters paired with SHAPER software, integrating cell suspension, thermoplastic, and biomaterial printing technologies under a single robotic control system.
Product overview
RegenHU offers a unified bioprinting platform consisting of the R-Gen 100 and R-Gen 200 3D bioprinters combined with SHAPER software. The platform combines multiple printing technologies (from cell suspensions to thermoplastic and biomaterial printing) in a single 3D bioprinting process. Applications include human skin printing for wound healing and cosmetic research, tablet printing for personalized medicine with high API loading, and cellular drug discovery models for target validation and disease modeling.
Differentiator
Problem solved
Functional benefit
Brands
- R-GEN 100: 3D bioprinter model for tissue models, drug development and tablet formulation
- R-GEN 200
- SHAPER
Products and services
- R-GEN 100 A 3D bioprinter designed for tissue models, drug development, and tablet formulation, combining multiple printing technologies (cell suspensions, thermoplastics, and biomaterials) in a single bioprinting process for academic and pharmaceutical researchers.
- R-GEN 200 An advanced 3D bioprinter for biofabrication applications including human skin printing, cellular drug discovery models, and personalized medicine, featuring precise robotic control and multi-technology printing capabilities for research and pharmaceutical users.
- SHAPER Bioprinting software that enables users to design 2D and 3D constructs, define materials and labware, manage the entire bioprinting project, specify calibration, dispensing parameters, and non-dispensing actions, and monitor processes in real time for biofabrication workflows.
Companies that use RegenHU
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles3 records
RegenHU technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
RegenHU partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
RegenHU competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
RegenHU social profiles
Digital presenceRegenHU financial estimates
Financial estimateRevenue estimate
Valuation estimate
RegenHU leadership team
Management profileNumber of profiles
RegenHU funding detail
Funding detailFunding overview
Funding rounds8 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RegenHU M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RegenHU
What does RegenHU do?
RegenHU develops, manufactures, and sells 3D bioprinting instruments and software used by research and pharmaceutical organizations to fabricate tissue models, drug discovery cellular models, and personalized pharmaceutical tablets. Its product platform comprises the R-GEN 100 and R-GEN 200 bioprinters paired with SHAPER software, integrating cell suspension, thermoplastic, and biomaterial printing technologies under a single robotic control system.
Is RegenHU a public or private company?
RegenHU is a private company. It is classified as venture growth investor backed and is currently operating.
When was RegenHU founded?
RegenHU was founded in 2007. It employs 11 to 50 people.
Where is RegenHU based?
RegenHU is headquartered in Villaz-saint-pierre, Switzerland, in the Europe region.
How does RegenHU make money?
Three revenue lines are on record. 3D Bioprinting Instruments are the primary driver. The others are software Licenses and support and Training Services.
Does RegenHU have an API?
No public API is recorded for RegenHU.
What industry is RegenHU in?
RegenHU's product category is 3D Bioprinting Instruments and Biofabrication Equipment. Its primary akta.pro industry code is IMAAAAAG, Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware), with a secondary code of HLAAAGAC, 3D Bioprinting & Biofabrication. Its NAICS code is 541714 and its SIC code is 3841.